Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Working in non-Covid-19 wards and night shifts is linked to higher infection rates among Italian nurses.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Skin and mucosal issues can occur after COVID-19 in adults and children.

Olive oil can help regrow hair lost due to COVID-19 or vaccination.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

COVID-19 may cause early hair loss by infecting hair follicles.

Hair loss occurred after a COVID-19 infection.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Testosterone may influence COVID-19 severity and outcomes.

Women with high androgen levels may have more severe COVID-19 symptoms.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Testosterone's effects on COVID-19 are unclear and need more research.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may cause temporary hair loss in some people.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Anti-androgens might help reduce COVID-19 severity in men.